➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Harvard Business School
AstraZeneca
Boehringer Ingelheim
Johnson and Johnson
McKesson

Last Updated: September 23, 2020

DrugPatentWatch Database Preview

OMEPRAZOLE MAGNESIUM - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for omeprazole magnesium and what is the scope of patent protection?

Omeprazole magnesium is the generic ingredient in three branded drugs marketed by Dr Reddys Labs Ltd, Spil, Covis Pharma Bv, Aurobindo Pharma Ltd, Hetero Labs Ltd Iii, P And L, Perrigo R And D, and Astrazeneca Pharms, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.

There are one hundred and thirty-one drug master file entries for omeprazole magnesium. Thirty-seven suppliers are listed for this compound.

Recent Clinical Trials for OMEPRAZOLE MAGNESIUM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Spero TherapeuticsPhase 1
Haining Health-Coming Biotech Co., Ltd.Phase 2
Radboud UniversityPhase 1

See all OMEPRAZOLE MAGNESIUM clinical trials

Pharmacology for OMEPRAZOLE MAGNESIUM
Paragraph IV (Patent) Challenges for OMEPRAZOLE MAGNESIUM
Tradename Dosage Ingredient NDA Submissiondate
PRILOSEC OTC TABLET, DELAYED RELEASE;ORAL omeprazole magnesium 021229 2012-03-30
PRILOSEC OTC TABLET, DELAYED RELEASE;ORAL omeprazole magnesium 021229 2007-03-19

US Patents and Regulatory Information for OMEPRAZOLE MAGNESIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Perrigo R And D OMEPRAZOLE MAGNESIUM omeprazole magnesium TABLET, DELAYED RELEASE;ORAL 204152-001 Jul 30, 2015 OTC No No   Start Trial   Start Trial   Start Trial
Spil OMEPRAZOLE MAGNESIUM omeprazole magnesium CAPSULE, DELAYED RELEASE;ORAL 210593-001 Jul 20, 2018 OTC No No   Start Trial   Start Trial   Start Trial
Covis Pharma Bv PRILOSEC omeprazole magnesium FOR SUSPENSION, DELAYED RELEASE;ORAL 022056-002 Mar 20, 2008 RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for OMEPRAZOLE MAGNESIUM

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Astrazeneca Pharms PRILOSEC OTC omeprazole magnesium TABLET, DELAYED RELEASE;ORAL 021229-001 Jun 20, 2003   Start Trial   Start Trial
Covis Pharma Bv PRILOSEC omeprazole magnesium FOR SUSPENSION, DELAYED RELEASE;ORAL 022056-001 Mar 20, 2008   Start Trial   Start Trial
Astrazeneca Pharms PRILOSEC OTC omeprazole magnesium TABLET, DELAYED RELEASE;ORAL 021229-001 Jun 20, 2003   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Boehringer Ingelheim
Baxter
Medtronic
Colorcon
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.